Literature DB >> 22433122

Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Manthos G Giannoulis, Finbarr C Martin, K Sreekumaran Nair, A Margot Umpleby, Peter Sonksen.   

Abstract

Improving physical function and mobility in a continuously expanding elderly population emerges as a high priority of medicine today. Muscle mass, strength/power, and maximal exercise capacity are major determinants of physical function, and all decline with aging. This contributes to the incidence of frailty and disability observed in older men. Furthermore, it facilitates the accumulation of body fat and development of insulin resistance. Muscle adaptation to exercise is strongly influenced by anabolic endocrine hormones and local load-sensitive autocrine/paracrine growth factors. GH, IGF-I, and testosterone (T) are directly involved in muscle adaptation to exercise because they promote muscle protein synthesis, whereas T and locally expressed IGF-I have been reported to activate muscle stem cells. Although exercise programs improve physical function, in the long-term most older men fail to comply. The GH/IGF-I axis and T levels decline markedly with aging, whereas accumulating evidence supports their indispensable role in maintaining physical function integrity. Several studies have reported that the administration of T improves lean body mass and maximal voluntary strength in healthy older men. On the other hand, most studies have shown that administration of GH alone failed to improve muscle strength despite amelioration of the detrimental somatic changes of aging. Both GH and T are anabolic agents that promote muscle protein synthesis and hypertrophy but work through separate mechanisms, and the combined administration of GH and T, albeit in only a few studies, has resulted in greater efficacy than either hormone alone. Although it is clear that this combined approach is effective, this review concludes that further studies are needed to assess the long-term efficacy and safety of combined hormone replacement therapy in older men before the medical rationale of prescribing hormone replacement therapy for combating the sarcopenia of aging can be established.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22433122      PMCID: PMC5393154          DOI: 10.1210/er.2012-1002

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  641 in total

1.  Effect of testosterone treatment on bone mineral density in men over 65 years of age.

Authors:  P J Snyder; H Peachey; P Hannoush; J A Berlin; L Loh; J H Holmes; A Dlewati; J Staley; J Santanna; S C Kapoor; M F Attie; J G Haddad; B L Strom
Journal:  J Clin Endocrinol Metab       Date:  1999-06       Impact factor: 5.958

2.  Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men.

Authors:  S Khosla; L J Melton; E J Atkinson; W M O'Fallon
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

3.  Early plateaus of power and torque gains during high- and low-speed resistance training of older women.

Authors:  Joseph F Signorile; Michelle P Carmel; Shenghan Lai; Bernard A Roos
Journal:  J Appl Physiol (1985)       Date:  2005-04

4.  Serum testosterone and sex hormone-binding globulin concentrations and the risk of prostate carcinoma: a longitudinal study.

Authors:  R Heikkilä; K Aho; M Heliövaara; M Hakama; J Marniemi; A Reunanen; P Knekt
Journal:  Cancer       Date:  1999-07-15       Impact factor: 6.860

Review 5.  Anabolic androgenic steroids and forebrain GABAergic transmission.

Authors:  L P Henderson; C A A Penatti; B L Jones; P Yang; A S Clark
Journal:  Neuroscience       Date:  2005-11-28       Impact factor: 3.590

6.  The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men.

Authors:  Chris J Malkin; Peter J Pugh; Richard D Jones; Dheeraj Kapoor; Kevin S Channer; T Hugh Jones
Journal:  J Clin Endocrinol Metab       Date:  2004-07       Impact factor: 5.958

7.  Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults.

Authors:  V Markussis; S A Beshyah; C Fisher; P Sharp; A N Nicolaides; D G Johnston
Journal:  Lancet       Date:  1992-11-14       Impact factor: 79.321

8.  The decline of serum testosterone levels in community-dwelling men over 70 years of age: descriptive data and predictors of longitudinal changes.

Authors:  B Lapauw; S Goemaere; H Zmierczak; I Van Pottelbergh; A Mahmoud; Y Taes; D De Bacquer; S Vansteelandt; J M Kaufman
Journal:  Eur J Endocrinol       Date:  2008-07-01       Impact factor: 6.664

9.  Altered metabolism of androgens in elderly men with benign prostatic hyperplasia.

Authors:  T Ishimaru; L Pages; R Horton
Journal:  J Clin Endocrinol Metab       Date:  1977-10       Impact factor: 5.958

10.  Does a functional activity programme improve function, quality of life, and falls for residents in long term care? Cluster randomised controlled trial.

Authors:  Ngaire Kerse; Kathy Peri; Elizabeth Robinson; Tim Wilkinson; Martin von Randow; Liz Kiata; John Parsons; Nancy Latham; Matthew Parsons; Jane Willingale; Paul Brown; Bruce Arroll
Journal:  BMJ       Date:  2008-10-09
View more
  42 in total

Review 1.  Eliminative signaling by Janus kinases: role in the downregulation of associated receptors.

Authors:  Christopher J Carbone; Serge Y Fuchs
Journal:  J Cell Biochem       Date:  2014-01       Impact factor: 4.429

2.  Application of Analyte Harvesting Nanoparticle Technology to the Measurement of Urinary HGH in Healthy Individuals.

Authors:  Alessandra Luchini; Davide Tamburro; Ruben Magni; Claudia Fredolini; Virginia Espina; Jaume Bosch; Enrico Garaci; Emanuel F Petricoin; Lance A Liotta
Journal:  J Sports Med Doping Stud       Date:  2012

3.  Sarcopenia and frailty: new challenges for clinical practice.

Authors:  Richard Dodds; Avan Aihie Sayer
Journal:  Clin Med (Lond)       Date:  2016-10       Impact factor: 2.659

Review 4.  The therapeutic potential of IGF-I in skeletal muscle repair.

Authors:  Yao-Hua Song; Jenny L Song; Patrice Delafontaine; Michael P Godard
Journal:  Trends Endocrinol Metab       Date:  2013-04-27       Impact factor: 12.015

5.  Effects of drugs on bone metabolism in a cohort of individuals with traumatic spinal cord injury.

Authors:  Christina Kokorelis; Marlis Gonzalez-Fernandez; Marjorie Morgan; Cristina Sadowsky
Journal:  Spinal Cord Ser Cases       Date:  2019-01-16

Review 6.  Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies.

Authors:  John A Batsis; Dennis T Villareal
Journal:  Nat Rev Endocrinol       Date:  2018-09       Impact factor: 43.330

Review 7.  Phenotypes of Obesity: How it Impacts Management.

Authors:  Meera Shah; Ryan T Hurt; Manpreet S Mundi
Journal:  Curr Gastroenterol Rep       Date:  2017-09-25

Review 8.  Multiple hormonal dysregulation as determinant of low physical performance and mobility in older persons.

Authors:  Marcello Maggio; Fulvio Lauretani; Francesca De Vita; Shehzad Basaria; Giuseppe Lippi; Valeria Butto; Michele Luci; Chiara Cattabiani; Graziano Ceresini; Ignazio Verzicco; Luigi Ferrucci; Gian Paolo Ceda
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

9.  Effects of Testosterone Supplementation on Body Composition in HIV Patients: A Meta-analysis of Double-blinded Randomized Controlled Trials.

Authors:  Ting Zhou; Zhi-Yong Hu; Hui-Ping Zhang; Kai Zhao; Yu Zhang; Ying Li; Jia-Jing Wei; Hong-Fang Yuan
Journal:  Curr Med Sci       Date:  2018-03-15

Review 10.  The role of muscle in bone repair: the cells, signals, and tissue responses to injury.

Authors:  Krupa Shah; Zahraa Majeed; Jennifer Jonason; Regis J O'Keefe
Journal:  Curr Osteoporos Rep       Date:  2013-06       Impact factor: 5.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.